Search - tctmd.com

Displaying 161 - 180 of 267

Sort: Relevancy | Date

News Daily News

La Implantación de Stents Ofrece Mejores Resultados Iniciales que Solo la Angioplastia en el Manejo de la EAP

Todd Neale

June 08, 2015

News Daily News

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

L.A. McKeown

May 11, 2015

News Industry News

Medtronic Initiates Study of 'In-Office' Insertion of Reveal LINQ(TM) Cardiac Monitor

May 07, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

Caitlin E. Cox

April 09, 2015

News Daily News

Risk Stratification Before PCI Ups Use of Bleeding Avoidance Strategies in High-Risk Patients

L.A. McKeown

April 03, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Conference News ACC 2015

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

L.A. McKeown

March 14, 2015

News Daily News

Supervised Exercise as Effective, Durable as Stenting in PAD Patients With Claudication

March 09, 2015

News Daily News

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Yael L. Maxwell

February 09, 2015

News Industry News

Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg

February 03, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Industry News

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

January 04, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

Periprocedural TAVR Complications Common, Costly

L.A. McKeown

November 02, 2014

News Daily News

Las Complicaciones Perioperatorias de la TAVR son Frecuentes y Costosas

L.A. McKeown

November 02, 2014

News Daily News

Study Suggests PFO Closure May Be Cost-Effective Over Long Term

Yael L. Maxwell

October 03, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

Economics May Lead to Shift in Process of Innovation

September 15, 2014

Advertisement

La Implantación de Stents Ofrece Mejores Resultados Iniciales que Solo la Angioplastia en el Manejo de la EAP

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

Medtronic Initiates Study of 'In-Office' Insertion of Reveal LINQ(TM) Cardiac Monitor

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

Risk Stratification Before PCI Ups Use of Bleeding Avoidance Strategies in High-Risk Patients

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

Supervised Exercise as Effective, Durable as Stenting in PAD Patients With Claudication

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Medtronic Starts U.S. Launch of IN.PACT Admiral Drug-Coated Balloon for Treatment of Peripheral Arterial Disease in Upper Leg

Long-term Ticagrelor Therapy Cost-Effective in US Patients

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Periprocedural TAVR Complications Common, Costly

Las Complicaciones Perioperatorias de la TAVR son Frecuentes y Costosas

Study Suggests PFO Closure May Be Cost-Effective Over Long Term

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

Economics May Lead to Shift in Process of Innovation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content